The incidence of hypertension, ATEs and gastrointestinal (GI) perforation in E2100 was consistent with that described in previous Avastin studies and detailed in the Avastin Prescribing Information.

• 2100研究中高血压、动脉血栓栓塞事件和消化道（胃肠）穿孔的发生率与以前贝伐单抗研究描述一致，详见贝伐单抗在处方资料。